Recruiting NCT07320118
Does Surgical Treatment of Cartilage Defects Prevent Osteoarthritis in Later Life?
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Osteoarthritis (OA). Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United Kingdom
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Cell Therapy for Osteoarthritis
Overview
Observational study to assess the effectiveness of cell therapy for the treatment of osteoarthritis
Primary outcome measures
- Cell Therapy Questionnaire [Time frame: At least fifteen months post operation]
Eligibility criteria
Inclusion criteria
- ACI patients or patients receiving an alternative treatment
Exclusion criteria
- Anyone who does not meet the inclusion criteria
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
United Kingdom · 2 centers
- The Robert Jones and Agnes Hunt Orthopaedic Hospital — Oswestry
- Robert Jones and Agnes Hunt Orthopaedic hospital — Oswestry
Identifiers
NCT: NCT07320118 · RL1 418